Slagle Financial’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22,748
Closed -$1.63M 134
2026
Q1
$1.63M Buy
22,748
+1,084
+5% +$83.5K 0.54% 65
2025
Q4
$1.72M Buy
21,664
+73
+0.3% +$5.75K 0.6% 63
2025
Q3
$1.63M Buy
21,591
+918
+4% +$62.9K 0.6% 62
2025
Q2
$1.43M Buy
20,673
+1,114
+6% +$73K 0.57% 62
2025
Q1
$1.33M Buy
+19,559
New +$1.17M 0.59% 57

Other funds holding CVS

Slagle Financial's CVS Position: Q2 2026 in Review

Slagle Financial sold out of CVS Health (CVS) in Q2 2026, closing a stake of 22,748 shares — an estimated $1.63M sold.

Slagle Financial first reported a position in CVS in Q1 2025 and held it in 5 quarters. The position peaked at $1.72M in Q4 2025. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Slagle Financial reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • Slagle Financial sold 22,748 CVS Health shares in Q2 2026, an estimated $1.63M.
  • Slagle Financial first reported a position in CVS Health in Q1 2025 and held it in 5 quarters.
  • Slagle Financial's CVS Health position peaked at $1.72M in Q4 2025.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Slagle Financial's 13F filing for Q2 2026, filed 29 Jul 2026.